3 Reasons to attend online:
1. Understand how to most efficiently develop global evidence that can best provide value to key local markets
2. Benchmark what are today’s and tomorrow’s ideal market access & cross-functional capabilities to maximise effectiveness in larger or smaller companies
3. Appreciate how to best leverage evidence to demonstrate value to key payers and HTAs
European Director Market Access
Global Access & Business Intelligence Manager
In today's demanding world of national requirements, how can companies develop the right evidence portfolio to succeed? How can they integrate evidence for payers with their regulatory studies? This in depth review will discuss core principles in evidence development for diagnostics and therapeutic medical devices, and how these concepts can align with the requirements of the major global markets -- the UK, France, Germany, Japan and the USA. Learn about the evolving landscape of evidence demands in:
European Director Market Access
We live in a world where researchers, healthcare providers, pharmaceuticals collaborate more closely than they used to. Collaboration requires information sharing and this brings the challenge of ensuring sensitive information is not shared. In google cloud, we have used ML approaches to build tools for de-identification of data, NLP and search to make finding information a little easier.
European Director Market Access
COVID-19 significantly impacted how providers reach out to patients. Besides, there has been a series of changes in the reimbursement and funding of medical technologies and procedures. These aspects created opportunities to address new market needs and leverage data and learning to deliver more value to a growing network of payers, providers, and patients. Welcome to the new era of Network Value.
Global Access & Business Intelligence Manager
Foundation Medicine Access Innovation and PHC Lead, Pharma International, F. Hoffmann-La Roche
Chair of the “Funding Medical Technologies” group, MedTech Europe
Markus A. Ott is a Global Medical Technology Professional with more than twenty years successful experience in international/global commercial & non-commercial roles he has become a highly effective and creative industry leader with extensive knowledge of the healthcare market.
Currently he is leading the Market Access & Health Policy department at Roche Diagnostics International (CPS) based in Rotkreuz/Switzerland.
His passion are all aspects of his job but primarily Value Based Healthcare & the digitalization of our industry.
He is/has been a member of global Management teams for various companies and associations. So, Markus has been member of the Executive Board of MedTech Europe as well as the Swiss Diagnostic Association. He acted as Chair Elect and Executive Board Member of EPPOSI (European Platform for Patient's Organizations, Science & Industry). Currently he chairs the HTA IVD & Value of Diagnostics Working groups @ MedTech Europe.
Finally, he is author of multiple publications as well as chair, panelist and speaker at many global conferences.
Vice President Market Access
Creative, international and multi-cultural business, communications and public affairs executive, lawyer and entrepreneur with results-driven management experience in business development, corporate and public affairs, government relations, corporate social responsibility, crisis management, branding and positioning, stakeholder engagement, product and corporate marketing, across industries-- from healthcare to not-for profit. Specialties: Strategic corporate communications, corporate affairs, government relations, crisis and issues management, perception management, employee and change management communications, media relations, marketing communications, labor relations, industry engagement, corporate responsibility, compliance communications, issues advocacy, multicultural communications.
Currently working as Vice President Market Access, Latin America at Medtronic. Previously worked as Vice President of Public Affairs and Director Communications Latin America Region at Baxter, and had several managing positions at Burson-Marsteller in past.
Vice President International Access, Policy & Advocacy
Benjamin Gannon joined Myriad Genetics in March 2019 and is responsible for international market access, policy and advocacy. Mr Gannon has over 20 years of European and international experience with the life sciences and biotech sector. Before joining Myriad, he was responsible for international government affairs, policy and patient engagement with Vertex Pharmaceuticals. In this role he established and led government affairs and patient engagement for Vertex’ operations internationally – this included support to market access strategy and regulatory policy. Mr Gannon is a Board member of EUCOPE, the European Confederation of Pharmaceutical Industries.
Before joining Vertex, Mr Gannon was Vice President for Group Public Affairs for SCA and has held senior government affairs and policy roles with Gilead, Johnson & Johnson and GlaxoSmithKline. He is a dual German/ UK national and holds Bachelor and Masters degrees in Biology from Southampton University (UK) and Imperial College (UK) respectively.
Vice President EMEA/LATAM
Financial Analysis for Nonfinancial Managers / University of Chicago Booth School of Business 2013
Truck Park Manager 1990-1991
Sales Rep FORD /Spec Sales Rep Commercial Vehicles 1991-1995
Sales Rep KFB Extramobile GmbH /Regional Manager East Emergency Vehicles 1996-2000
Territory Manager Resuscitation Business ZOLL Medical Deutschland 2000-2008
Sales Manager Resuscitation Business ZOLL Medical Deutschland/Österreich 2008-2010
Country Manager ZOLL Medical Deutschland/Österreich/Schweiz (DACH) Temperature Management 2010-2018
Manager Temp Management Europe ZOLL Medical 2018-2019
Manager Temp Management EMEA/LATAM ZOLL Circulation 2019-….
Geschäftsführer ZOLL Medical Switzerland AG und ZOLL Medical Österreich GmbH
Prokurist ZOLL Medical Deutschland GmbH
Senior Manager Health Policy & Economics
My name is Dr. Frank Semrau, I was born and went to school in the northern part of Germany (Lüneburg near Hamburg). I studied Biology in Göttingen and got the Diploma in Biology (Biochemistry, Microbiology) at the Georg-August University of Göttingen. I conducted my thesis at the University Hospital of Göttingen, Center for Hygiene and Human Genetics and got a PhD from Georg-August University of Göttingen (Biochemistry, Medical Microbiology), as well.
I started my business career at, then, one of the 10 biggest pharmaceutical companies Pharmacia which merged with Pfizer some years later, as a Regional Manager Health Politics, dealing with Associations of Statutory Health Insurance Physicians which control ambulatory prescriptions of pharmaceuticals.
In 2004 the DRG system was introduced in Germany and I attended and supported the implementation as a Manager Health Economics/Government Affairs with Boston Scientific (Medical devices) for almost nine years, the last years as a department deputy. While I started with responsibility for all products, with growing department I specialized in vascular and cardiac medical technologies like stents, ICDs and pacemaker.
Since 2012 I am with ZOLL CMS as a Strategic Reimbursement Manager for European countries. I am responsible for European market access and reimbursement of the wearable cardioverter defibrillator (WCD) “LifeVest” with a strong focus on Germany. From this point of view I have a very broadly defined idea of MA & Reimbursement, including preparation and optimization of reimbursement applications and coding, as well as initiating support by physicians, clinical studies, guidelines, patient organizations, health economic assessments and models, HTAs, pricing, politics, PR and social opinion. Currently my main goal is the seamless protection of patients with high risk for sudden cardiac death (SCD) in and particularly outside the hospital.
Director, Government Affairs, Policy & Health Economics
MASSIMO G. BARBERIO is actually GovernmentAffairs, Policy& Health Economics Director Italy in GE Healthcare Italy He started his career working in the commercial department of a medium size pharmaceutical company, dealing with diagnostic hospital pharma products. After several assignments in marketing field for several large pharmaceutical companies, in 2007 he joined GE Healthcare, as South Europe Marketing Director for the Pharmaceutical Division.Since 2011Massimocovers the role of GovernmentAffairs, Policy& Health Economics Director Italy in GE HealthcareMedical Systems, dealing with the technological and pharmaceutical product portfolio and managing the Market Access activities in General Electric Healthcare. In his activity he managesthe Company official relationships with Institutions like Government and Parliament members, Health and University Ministry, Government Agencies, Professional Societies. He is in the staff of the Southern Europe President of GE Healthcare. He is member of the Italian Society of Clinical Radiology since 1995, and he is also part of the Italian Association of Nuclear Medicine, Massimo obtained also several academic assignments: appointed as Visiting Professor at the Radiology School of the Medicine Faculty at the Milano Bicocca University and as lecturer at the MBA courses at L. Bocconi University and Management School in Milan and at LUISS University in Rome, he is actually Visiting Professor at the Research Centre for study on Healthcare Management at the LIUC University of Castellanza and member of the steering committee and Professor atthe School of Finance and Management at Universitàdel Piemonte Orientale di Novara. He is author of several clinical and pharmacoeconomy papers published on some national and international peer reviewed journals, as the Italian Journal of Radiology and the California Management Review. He has a master’sdegree in Biology and a Master in Strategic Marketingandalso MasterinHealthcareEconomy and Management Born in Milan 60years ago,Massimo is married with Angela and they have one son, Daniele, 31years old and one daughter, Martina 27years old. He enjoys spending his time with his family and reading, and after a brilliant career as Italian major league Handball referee, actually his sport activity is limited todiscussions with friends on soccer games seen on TV.
Director, Market Access – EMEA
Marcus has worked in medical devices for longer than he would care to admit. He began his career in UK hospitals as a cardiac technician. After only eight years he joined St Jude Medical as a junior member of the UK clinical operations team. Quickly promoted to the European headquarters he spent a number of years in Brussels performing various roles in clinical trials and medical affairs covering both European and International markets before crossing over to the market access team, again supporting both European and international markets. Marcus left St Jude to join Second Sight, a small company pioneering retinal implant technology. Marcus is currently the European market access head for Teleflex. He lives in Brussels with his wife and two children.
Director, Market Access and Reimbursement Affairs
Stephanie Ibbotson heads the Market Access and Reimbursement Affairs department at Luminex Corporation. Stephanie joined Luminex in 2015 where she developed the Strategic Marketing department. Stephanie holds a BSc in Genetics from Western University, an MBA from Laurier University, an MPH from the University of Liverpool and is a certified management accountant. Stephanie is passionate about healthcare reform and as the associate director of MDx for QIAGEN, worked with the provincial health systems in Canada to implement a new cervical cancer prevention program. In her current role Stephanie is focused on building clinical utility evidence for syndromic assays to achieve value-based reimbursement coverage.
International Sales Director Italy, Central Europe, Russia and Eurasia
Nicolas holds a Master in Business from ESSEC (2008) and a master in History from the Sorbonne University in Paris (2005).
Having started as a consultant for Izsak Grapin & Associés in 2006 where he worked noticeably for ROCHE Pharma, he joined the Consumer Products division of L’OREAL in 2010 as a territory Manager to develop sales through the structuring and the optimization of the local distribution network. In 2012, he integrated L’OREAL Marketing team in Paris to reinforce the Matrix haircare brand in France.
After 2 years with Septodont where he managed and developed the international distribution network in the CIS Countries, he joins Echosens in 2017 where he currently works as International Sales Director for Italy, Central Europe, Russia and Eurasia.
Business Development Director
Julya A. Zuenkova, MD, has a medical background working as clinical doctor and healthcare deputy director, implemented LEAN and clinical audits into Russian healthcare system, uses social marketing tools.
From 2010 she is working in MedTech field and has a big experience in manufacturing companies and also distributor company experience. She was working with different types of medical devices – innovative devices, consumables and capital equipment at radiology, cardiology, endovascular fields.
Within her career she was working in emerging markets: Russia, CIS and participated in APAC and EMEA projects.
Julya Zuenkova has marketing degree and is a Certificated Expert in Marketing Communication, Member of Marketing Guild Union.
Managing Director, MD squared
Claus is a physician and electrical engineer with more than 20 years of experience in the hospital and medical device industry. He is the founder of MD squared, a Medical Consultancy for Medical Devices. MD squared’s passioned and inter-disciplinary team of experts helps you to make informed choices to optimize the value of your Medical Device during development, market introduction and throughout its life cycle. In our structured programs we help you to systematically translate clinical and regulatory requirements into differentiating Product Claims and demonstrated patient and economical benefit.
Principal and Founder
Stephen Hull is Principal and Founder of Hull Associates LLC, a specialized global reimbursement and market access consultancy. He and his firm leverage over 25 years of experience in US and global reimbursement and in-market expertise on behalf of pharma, medical device and diagnostics Clients. Prior to forming Hull Associates in 2007, he served as SVP for Global Reimbursement at AdvaMed, in Washington, D.C. and as chair of the ISPOR Medical Devices Council. Stephen holds a Master’s degree in health policy from the Johns Hopkins Bloomberg School of Public Health, and a bachelor’s degree in international relations and French from Colgate University.
Sr. Consultant Health Economics, MD squared
Professor & Head of Health Economics & Healthcare Management Division, Kozminski University
Driven with the passion to health economics, I have more than 20 years of academic and industry experience in the field of healthcare. Holding various Regional and Global leadership positions, I have been working extensively within public health sector as well as pharma and medtech industry.
After six years employment at the Kalmar County Council in Sweden, I held global and regional Health Economics & Outcomes Research (HEOR) positions at AstraZeneca and BiogenIdec respectively. At Bristol Myers Squibb and Lundbeck I lead Market Access teams in Central Eastern European (CEE) and Nordic Region. In the last five years, I gained experience with the pricing &reimbursement challenges in the field of medical devices. I supported Straub Medical as Global Market Access Lead. Before that, I was Senior Sales Director responsible for HEOR at GE Healthcare.
Since 2018 I am a Professor at the Kozminski University heading Health Economics & Healthcare Management Division (HeM). I am the leader of the International Master Program Health Economics & Big Data (HEBDA) financed by the EU research grant. In October 2020, I was nominated to the ISPOR’s Health Sciences Policy Council (HSPC). Since January 2020, I am chair elect of ISPOR Special Interest Group Digital Health as well.
My biggest strength is the market access planning for a successful pricing & reimbursement strategy. Knowledgably of HTA guidelines, DRG financing and hospital procurement pathways across EU & US settings, I will be able to advice on the optimal market entry that ensures the best differentiation of a given technology against alternative treatment options
CEO and Founder
Ernesto is the Founder and Managing Director of ValueConnected. He has over 23
years of experience leading healthcare strategies to drive access and expansion for new products, developing value propositions for both public and private stakeholders and assessing global market opportunities. He has worked for both government agencies and global healthcare companies in roles ranging from strategic marketing and new product development to health economics and reimbursement. Ernesto has led several Market Access projects across Europe, US, Middle East and Latin America. Ernesto holds an MBA from the University of Texas at Austin and is fluent in English, Spanish and Portuguese.
Senior Director, Business Partnerships
Luke Rogers is the Senior Director of Business Partnerships at Within3. Luke's background includes degrees in Business, Science & a Masters' in Health Economics. He's worked for almost 15 years in Life Sciences in Live Events, including Running & Moderating Advisory Boards, Investigator Meetings, Payer Panels & Large Congresses. Luke's role is to assist Life Sciences clients of all sizes and scopes to operationalize their digital strategy, particularly around Stakeholder Engagement.